Valius Sciences

Valius Sciences

Multi-omic cancer diagnostics with data platform

Overview

Valius Sciences develops precision oncology diagnostics that build detailed molecular profiles of tumors across DNA, RNA, and proteins to guide treatment choices. Its test combines multi-omic data and extensive gene expression analysis to identify actionable targets and cancer drivers that may be missed by standard tests. Rather than static PDFs, it offers a partnership model with an AI-queryable platform that stores all patient data and enables ongoing analysis and collaboration with Valius's scientific team. The goal is to help patients and clinicians prioritize effective therapies and plan for recurrence or progression through continuous, data-driven insights.

Launched Recently

About Valius Sciences

Simplify's Rating
Why Valius Sciences is rated
C-
Rated C on Competitive Edge
Rated C on Growth Potential
Rated D+ on Differentiation

Industries

Data & Analytics

AI & Machine Learning

Biotechnology

Healthcare

Company Size

N/A

Company Stage

Seed

Total Funding

$10M

Headquarters

San Francisco, California

Founded

2025

People at Valius Sciences

People at Valius Sciences who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Valius raised $13.5M in April 2026 to expand its multi-omic platform.
  • Founders combine expertise from Palantir, Bain, and Takeda for commercial and scientific depth.
  • The partnership model improves collaboration between patients and care teams for personalized strategies.

What critics are saying

  • Guardant Health's liquid biopsy displaces Valius's invasive tissue workflow with 35% market capture.
  • Myriad Genetics' ubleSeq offers FDA-cleared multi-omic analysis at 60% lower cost.
  • The 2025 seed funding lacks sufficient capital for three-year R&D, risking liquidity collapse.

What makes Valius Sciences unique

  • Valius maps cancer across DNA, RNA, and protein for maximalist diagnostic coverage.
  • The company offers an AI-queryable partnership model instead of static PDF reports.
  • Valius analyzes tumor behavior against thousands of samples to identify actionable targets.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$10M

Above

Industry Average

Funded Over

1 Rounds

Seed funding is usually the first official round after pre-seed, when a startup has a prototype or concept. It’s typically used to develop the product, test the market, and start building the team. Investors here are often angel investors or early-stage venture capitalists.
Seed Funding Comparison
Above Average

Industry standards

$3.3M
$2M
Netflix
$2.3M
Instacart
$3M
Robinhood
$10M
Valius Sciences

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Company Equity

Professional Development Budget

Recently Posted Jobs

Sign up to get curated job recommendations

Valius Sciences is Hiring for 8 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →